[{"id":"fb5a3d64-2b8f-44c4-84f0-e927e52ab2a1","acronym":"","url":"https://clinicaltrials.gov/study/NCT04939051","created_at":"2024-02-29T18:31:43.001Z","updated_at":"2025-02-25T13:35:51.854Z","phase":"Phase 2","brief_title":"Obeticholic Acid for Prevention in Barrett's Esophagus","source_id_and_acronym":"NCT04939051","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" FGF19 • SOX2 • CASP3 • FGF • CDX2","pipe":"","alterations":" ","tags":["FGF19 • SOX2 • CASP3 • FGF • CDX2"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 01/03/2024","start_date":" 01/03/2024","primary_txt":" Primary completion: 09/29/2025","primary_completion_date":" 09/29/2025","study_txt":" Completion: 09/29/2026","study_completion_date":" 09/29/2026","last_update_posted":"2025-02-21"},{"id":"f77d9cea-50f0-4134-ad94-b3aac597f423","acronym":"","url":"https://clinicaltrials.gov/study/NCT05709574","created_at":"2024-03-18T14:22:00.111Z","updated_at":"2024-07-02T16:35:14.329Z","phase":"Phase 2","brief_title":"Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ Cancer","source_id_and_acronym":"NCT05709574","lead_sponsor":"University of Arizona","biomarkers":" TLR9 • CDX2 • MIR30B","pipe":" | ","alterations":" TLR9 expression","tags":["TLR9 • CDX2 • MIR30B"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TLR9 expression"],"overall_status":"Recruiting","enrollment":" Enrollment 10","initiation":"Initiation: 04/20/2023","start_date":" 04/20/2023","primary_txt":" Primary completion: 03/01/2025","primary_completion_date":" 03/01/2025","study_txt":" Completion: 05/01/2025","study_completion_date":" 05/01/2025","last_update_posted":"2024-03-18"},{"id":"fa58d62b-eb7a-4259-85da-03ca35c7b9bd","acronym":"CHORDOMES","url":"https://clinicaltrials.gov/study/NCT04486820","created_at":"2021-01-18T21:32:20.614Z","updated_at":"2024-07-02T16:36:42.757Z","phase":"","brief_title":"Immunohistochemical Study of Chordomas to Improve Their Diagnosis and Prognosis Care","source_id_and_acronym":"NCT04486820 - CHORDOMES","lead_sponsor":"Centre Hospitalier Universitaire de Saint Etienne","biomarkers":" PD-L1 • CD8 • FOXA1 • CDX2 • INSM1","pipe":" | ","alterations":" PD-L1 expression • CDX-2 expression","tags":["PD-L1 • CD8 • FOXA1 • CDX2 • INSM1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PD-L1 expression • CDX-2 expression"],"overall_status":"Completed","enrollment":" Enrollment 40","initiation":"Initiation: 04/01/2020","start_date":" 04/01/2020","primary_txt":" Primary completion: 07/01/2020","primary_completion_date":" 07/01/2020","study_txt":" Completion: 07/01/2020","study_completion_date":" 07/01/2020","last_update_posted":"2020-07-27"}]